[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Primary Hyperoxaluria Drug Market Report 2018

January 2018 | 100 pages | ID: U0BE555ADC6EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Primary Hyperoxaluria Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Primary Hyperoxaluria Drug in these regions, from 2013 to 2025 (forecast).
United States Primary Hyperoxaluria Drug market competition by top manufacturers/players, with Primary Hyperoxaluria Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Allena Pharmaceuticals Inc
  • Alnylam Pharmaceuticals Inc
  • Dicerna Pharmaceuticals Inc
  • Intellia Therapeutics Inc
  • OxThera AB
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • ALLN-230
  • DCR-PHXC
  • ALN-GO1
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Primary Hyperoxaluria Drug Market Report 2018

1 PRIMARY HYPEROXALURIA DRUG OVERVIEW

1.1 Product Overview and Scope of Primary Hyperoxaluria Drug
1.2 Classification of Primary Hyperoxaluria Drug by Product Category
  1.2.1 United States Primary Hyperoxaluria Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Primary Hyperoxaluria Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 ALLN-230
  1.2.4 DCR-PHXC
  1.2.5 ALN-GO1
  1.2.6 Others
1.3 United States Primary Hyperoxaluria Drug Market by Application/End Users
  1.3.1 United States Primary Hyperoxaluria Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Primary Hyperoxaluria Drug Market by Region
  1.4.1 United States Primary Hyperoxaluria Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
  1.4.5 New England Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
  1.4.6 The South Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Primary Hyperoxaluria Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Primary Hyperoxaluria Drug (2013-2025)
  1.5.1 United States Primary Hyperoxaluria Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Primary Hyperoxaluria Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES PRIMARY HYPEROXALURIA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Primary Hyperoxaluria Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Primary Hyperoxaluria Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Primary Hyperoxaluria Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Primary Hyperoxaluria Drug Market Competitive Situation and Trends
  2.4.1 United States Primary Hyperoxaluria Drug Market Concentration Rate
  2.4.2 United States Primary Hyperoxaluria Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Primary Hyperoxaluria Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PRIMARY HYPEROXALURIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Primary Hyperoxaluria Drug Sales and Market Share by Region (2013-2018)
3.2 United States Primary Hyperoxaluria Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Primary Hyperoxaluria Drug Price by Region (2013-2018)

4 UNITED STATES PRIMARY HYPEROXALURIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Primary Hyperoxaluria Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Primary Hyperoxaluria Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Primary Hyperoxaluria Drug Price by Type (2013-2018)
4.4 United States Primary Hyperoxaluria Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PRIMARY HYPEROXALURIA DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Primary Hyperoxaluria Drug Sales and Market Share by Application (2013-2018)
5.2 United States Primary Hyperoxaluria Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PRIMARY HYPEROXALURIA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allena Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Primary Hyperoxaluria Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Alnylam Pharmaceuticals Inc
  6.2.2 Primary Hyperoxaluria Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Dicerna Pharmaceuticals Inc
  6.3.2 Primary Hyperoxaluria Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Intellia Therapeutics Inc
  6.4.2 Primary Hyperoxaluria Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 OxThera AB
  6.5.2 Primary Hyperoxaluria Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 OxThera AB Primary Hyperoxaluria Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 PRIMARY HYPEROXALURIA DRUG MANUFACTURING COST ANALYSIS

7.1 Primary Hyperoxaluria Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Primary Hyperoxaluria Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Primary Hyperoxaluria Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Primary Hyperoxaluria Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PRIMARY HYPEROXALURIA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Primary Hyperoxaluria Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Primary Hyperoxaluria Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Primary Hyperoxaluria Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Primary Hyperoxaluria Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Primary Hyperoxaluria Drug
Figure United States Primary Hyperoxaluria Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure ALLN-230 Product Picture
Figure DCR-PHXC Product Picture
Figure ALN-GO1 Product Picture
Figure Others Product Picture
Figure United States Primary Hyperoxaluria Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Primary Hyperoxaluria Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Primary Hyperoxaluria Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Primary Hyperoxaluria Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Primary Hyperoxaluria Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Primary Hyperoxaluria Drug Sales Share by Players/Suppliers
Figure 2017 United States Primary Hyperoxaluria Drug Sales Share by Players/Suppliers
Figure United States Primary Hyperoxaluria Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Primary Hyperoxaluria Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Primary Hyperoxaluria Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Primary Hyperoxaluria Drug Revenue Share by Players/Suppliers
Figure 2017 United States Primary Hyperoxaluria Drug Revenue Share by Players/Suppliers
Table United States Market Primary Hyperoxaluria Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Primary Hyperoxaluria Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Primary Hyperoxaluria Drug Market Share of Top 3 Players/Suppliers
Figure United States Primary Hyperoxaluria Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Primary Hyperoxaluria Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Primary Hyperoxaluria Drug Product Category
Table United States Primary Hyperoxaluria Drug Sales (K Pcs) by Region (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales Share by Region (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Share by Region (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Market Share by Region in 2017
Table United States Primary Hyperoxaluria Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Primary Hyperoxaluria Drug Revenue Share by Region (2013-2018)
Figure United States Primary Hyperoxaluria Drug Revenue Market Share by Region (2013-2018)
Figure United States Primary Hyperoxaluria Drug Revenue Market Share by Region in 2017
Table United States Primary Hyperoxaluria Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales (K Pcs) by Type (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales Share by Type (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Share by Type (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Market Share by Type in 2017
Table United States Primary Hyperoxaluria Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Primary Hyperoxaluria Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Primary Hyperoxaluria Drug by Type (2013-2018)
Figure Revenue Market Share of Primary Hyperoxaluria Drug by Type in 2017
Table United States Primary Hyperoxaluria Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Growth Rate by Type (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales (K Pcs) by Application (2013-2018)
Table United States Primary Hyperoxaluria Drug Sales Market Share by Application (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Market Share by Application (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Market Share by Application in 2017
Table United States Primary Hyperoxaluria Drug Sales Growth Rate by Application (2013-2018)
Figure United States Primary Hyperoxaluria Drug Sales Growth Rate by Application (2013-2018)
Table Allena Pharmaceuticals Inc Basic Information List
Table Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Growth Rate (2013-2018)
Figure Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Market Share in United States (2013-2018)
Figure Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Market Share in United States (2013-2018)
Table Alnylam Pharmaceuticals Inc Basic Information List
Table Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Growth Rate (2013-2018)
Figure Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Market Share in United States (2013-2018)
Figure Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Market Share in United States (2013-2018)
Table Dicerna Pharmaceuticals Inc Basic Information List
Table Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Growth Rate (2013-2018)
Figure Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Sales Market Share in United States (2013-2018)
Figure Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Revenue Market Share in United States (2013-2018)
Table Intellia Therapeutics Inc Basic Information List
Table Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Growth Rate (2013-2018)
Figure Intellia Therapeutics Inc Primary Hyperoxaluria Drug Sales Market Share in United States (2013-2018)
Figure Intellia Therapeutics Inc Primary Hyperoxaluria Drug Revenue Market Share in United States (2013-2018)
Table OxThera AB Basic Information List
Table OxThera AB Primary Hyperoxaluria Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure OxThera AB Primary Hyperoxaluria Drug Sales Growth Rate (2013-2018)
Figure OxThera AB Primary Hyperoxaluria Drug Sales Market Share in United States (2013-2018)
Figure OxThera AB Primary Hyperoxaluria Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Hyperoxaluria Drug
Figure Manufacturing Process Analysis of Primary Hyperoxaluria Drug
Figure Primary Hyperoxaluria Drug Industrial Chain Analysis
Table Raw Materials Sources of Primary Hyperoxaluria Drug Major Players/Suppliers in 2017
Table Major Buyers of Primary Hyperoxaluria Drug
Table Distributors/Traders List
Figure United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Primary Hyperoxaluria Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Primary Hyperoxaluria Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Primary Hyperoxaluria Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Primary Hyperoxaluria Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Primary Hyperoxaluria Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications